NASDAQ:GRI | Free Cash Flow | GRI Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.69M
2025-12-31-$2.97M
2025-03-31-$1.74M
2024-12-31-$2M$0.00-$2M
2024-03-31-$2.2M
2023-12-31-$5.56M$0.00-$5.56M
2023-03-31-$579,000.00
2022-12-31-$844,000.00$3,000.00-$847,000.00
2022-03-31-$2.29M
2021-12-31-$1.58M$0.00-$1.58M
2021-03-31-$2.95M
2020-12-31-$808,000.00$0.00-$808,000.00
2020-03-31-$766,000.00$2,000.00-$768,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.19M$3,000.00-$10.19M
2024-12-31-$8.61M$0.00-$8.61M
2023-12-31-$8.99M$8,000.00-$9M
2022-12-31-$1.09M$3,000.00-$1.09M
2021-12-31-$8.31M$0.00-$8.31M
2020-12-31-$3.71M$2,000.00-$3.71M